Imprint databases are mostly US-centric. A confident hit for another market is still a guess.
Sorry, probably obvious, but where do you even start with something blank? Not on the batch number but the pattern is familiar.
Daylight, no flash.
It gets smaller. Not easy, smaller. That distinction kept me going.
Same here.
It gets smaller. Not easy, smaller. That distinction kept me going.
Ten percent cuts, of the current dose not the original. That is the arithmetic that keeps it survivable.
Imprint first, country second, colour last. And photograph both sides in daylight. Currently on the batch number myself.
Small wins count. Walking to the mailbox is a data point.
Sorry, probably obvious, but where do you even start with something blank?
Same here.
Small wins count. Walking to the mailbox is a data point.
Interdose restlessness is distinct from the original symptom and worth naming separately.
Take one to a pharmacist. Free, two minutes, correct. Everything else here is a hypothesis.
The pain score conversation is thirty seconds of my life I will never get back, every time.